OCS Oaktree Specialty Lending: Net earnings per share for the last four quarters

Oaktree Specialty Lending (OCS) - corporate logo

The year-over-year change in EPS (TTM) demonstrates profit dynamics, where 31.20 shows the value of this parameter. A Swiss startup is currently finalizing innovation tests and seeking a major partner. The company is implementing painless retinal drops to replace injections. Simultaneously, Oaktree Specialty Lending (OCS) leverages its expertise in distressed debt to find opportunities during market disruptions.

Oculis (OCS): Net earnings per share (EPS TTM) from 02/11/2024 to 11/18/2026

Financial and market metric breakdowns for Oculis Pharma (OCS)

- price and consensus price forecast:
Initial company analysis:Oculis Holding AG OCS
Mass-produced product of Oculis AG

The rolling annual growth of net income per share measures the pace of operational efficiency recovery, capturing the actual speed of dividend stream accumulation through EPS dynamics. By analyzing the annual EPS TTM growth, an investor assesses how the high scientific reputation of Oaktree Specialty Lending (OCS) in biopharmaceuticals converts into financial results, determining the stability of the investment profile during a period of post-crisis growth.

Competitor analysis for Oaktree Specialty Lending

Net earnings per one share for the last twelve months Alcon Inc|BLCO: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Glaukos Medical (GKOS)|Earnings per share for the last twelve months apellis.com|Belite Bio (BLTE) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Ocular Pharma (OCUL)|HROW (Harrow) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) VRDN (Viridian Corp)|LENZ Corp (LENZ) - Net earnings per one share for the last twelve months|EyePoint Pharmaceuticals Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Kodiak Sciences Inc. KOD|ALDX: Net earnings per share (EPS TTM)|KALA BIO, Inc. (KALA) - Net earnings per share (EPS TTM)|IRD (Opus Genetics Inc) - Net earnings per share (EPS TTM)|OKYO: Earnings per share for the trailing year|Net earnings per share for the last 12 months ADVM (adverum.com)|OTLK - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CLSD (Clearside Biomedical Inc)|Earnings per share for the trailing year NBY|Kiora Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ALIM (Alimera Sciences, Inc.)|EYEN (Eyenovia Corp) - Net earnings per share for the last 12 months|Guardion Health Science - Earnings per share for the trailing year|Earnings per share for the last twelve months Ocuphire Pharma, Inc.|Opthea Ltd. (OPT) - Net earnings per share for the last four quarters